Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering

Abstract Lipid nanoparticles (LNPs) are the preeminent non-viral drug delivery vehicle for mRNA-based therapies. Immense effort has been placed on optimizing the ionizable lipid (IL) structure, which contains an amine core conjugated to lipid tails, as small molecular adjustments can result in subst...

Full description

Saved in:
Bibliographic Details
Main Authors: Marshall S. Padilla, Kaitlin Mrksich, Yiming Wang, Rebecca M. Haley, Jacqueline J. Li, Emily L. Han, Rakan El-Mayta, Emily H. Kim, Sofia Dias, Ningqiang Gong, Sridatta V. Teerdhala, Xuexiang Han, Vivek Chowdhary, Lulu Xue, Zain Siddiqui, Hannah M. Yamagata, Dongyoon Kim, Il-Chul Yoon, James M. Wilson, Ravi Radhakrishnan, Michael J. Mitchell
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-55137-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585583234383872
author Marshall S. Padilla
Kaitlin Mrksich
Yiming Wang
Rebecca M. Haley
Jacqueline J. Li
Emily L. Han
Rakan El-Mayta
Emily H. Kim
Sofia Dias
Ningqiang Gong
Sridatta V. Teerdhala
Xuexiang Han
Vivek Chowdhary
Lulu Xue
Zain Siddiqui
Hannah M. Yamagata
Dongyoon Kim
Il-Chul Yoon
James M. Wilson
Ravi Radhakrishnan
Michael J. Mitchell
author_facet Marshall S. Padilla
Kaitlin Mrksich
Yiming Wang
Rebecca M. Haley
Jacqueline J. Li
Emily L. Han
Rakan El-Mayta
Emily H. Kim
Sofia Dias
Ningqiang Gong
Sridatta V. Teerdhala
Xuexiang Han
Vivek Chowdhary
Lulu Xue
Zain Siddiqui
Hannah M. Yamagata
Dongyoon Kim
Il-Chul Yoon
James M. Wilson
Ravi Radhakrishnan
Michael J. Mitchell
author_sort Marshall S. Padilla
collection DOAJ
description Abstract Lipid nanoparticles (LNPs) are the preeminent non-viral drug delivery vehicle for mRNA-based therapies. Immense effort has been placed on optimizing the ionizable lipid (IL) structure, which contains an amine core conjugated to lipid tails, as small molecular adjustments can result in substantial changes in the overall efficacy of the resulting LNPs. However, despite some advancements, a major barrier for LNP delivery is endosomal escape. Here, we develop a platform for synthesizing a class of branched ILs that improve endosomal escape. These compounds incorporate terminally branched groups that increase hepatic mRNA and ribonucleoprotein complex delivery and gene editing efficiency as well as T cell transfection compared to non-branched lipids. Through an array of complementary experiments, we determine that our lipid architecture induces greater endosomal penetration and disruption. This work provides a scheme to generate a class of ILs for both mRNA and protein delivery.
format Article
id doaj-art-a75439f6733b4f3f9a9cda7f6f310cf5
institution Kabale University
issn 2041-1723
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-a75439f6733b4f3f9a9cda7f6f310cf52025-01-26T12:40:45ZengNature PortfolioNature Communications2041-17232025-01-0116111910.1038/s41467-024-55137-6Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineeringMarshall S. Padilla0Kaitlin Mrksich1Yiming Wang2Rebecca M. Haley3Jacqueline J. Li4Emily L. Han5Rakan El-Mayta6Emily H. Kim7Sofia Dias8Ningqiang Gong9Sridatta V. Teerdhala10Xuexiang Han11Vivek Chowdhary12Lulu Xue13Zain Siddiqui14Hannah M. Yamagata15Dongyoon Kim16Il-Chul Yoon17James M. Wilson18Ravi Radhakrishnan19Michael J. Mitchell20Department of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaGene Therapy Program, Perelman School of Medicine, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaGene Therapy Program, Perelman School of Medicine, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaDepartment of Bioengineering, School of Engineering and Applied Science, University of PennsylvaniaAbstract Lipid nanoparticles (LNPs) are the preeminent non-viral drug delivery vehicle for mRNA-based therapies. Immense effort has been placed on optimizing the ionizable lipid (IL) structure, which contains an amine core conjugated to lipid tails, as small molecular adjustments can result in substantial changes in the overall efficacy of the resulting LNPs. However, despite some advancements, a major barrier for LNP delivery is endosomal escape. Here, we develop a platform for synthesizing a class of branched ILs that improve endosomal escape. These compounds incorporate terminally branched groups that increase hepatic mRNA and ribonucleoprotein complex delivery and gene editing efficiency as well as T cell transfection compared to non-branched lipids. Through an array of complementary experiments, we determine that our lipid architecture induces greater endosomal penetration and disruption. This work provides a scheme to generate a class of ILs for both mRNA and protein delivery.https://doi.org/10.1038/s41467-024-55137-6
spellingShingle Marshall S. Padilla
Kaitlin Mrksich
Yiming Wang
Rebecca M. Haley
Jacqueline J. Li
Emily L. Han
Rakan El-Mayta
Emily H. Kim
Sofia Dias
Ningqiang Gong
Sridatta V. Teerdhala
Xuexiang Han
Vivek Chowdhary
Lulu Xue
Zain Siddiqui
Hannah M. Yamagata
Dongyoon Kim
Il-Chul Yoon
James M. Wilson
Ravi Radhakrishnan
Michael J. Mitchell
Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering
Nature Communications
title Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering
title_full Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering
title_fullStr Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering
title_full_unstemmed Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering
title_short Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering
title_sort branched endosomal disruptor bend lipids mediate delivery of mrna and crispr cas9 ribonucleoprotein complex for hepatic gene editing and t cell engineering
url https://doi.org/10.1038/s41467-024-55137-6
work_keys_str_mv AT marshallspadilla branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT kaitlinmrksich branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT yimingwang branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT rebeccamhaley branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT jacquelinejli branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT emilylhan branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT rakanelmayta branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT emilyhkim branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT sofiadias branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT ningqianggong branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT sridattavteerdhala branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT xuexianghan branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT vivekchowdhary branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT luluxue branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT zainsiddiqui branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT hannahmyamagata branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT dongyoonkim branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT ilchulyoon branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT jamesmwilson branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT raviradhakrishnan branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering
AT michaeljmitchell branchedendosomaldisruptorbendlipidsmediatedeliveryofmrnaandcrisprcas9ribonucleoproteincomplexforhepaticgeneeditingandtcellengineering